NYMOX PHARMACEUTICAL CORP

9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC, CANADA H4M 2V2 A8, 514-332-3222
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

2000 SEC Filings

NYMOX PHARMACEUTICAL CORP, 6-K, 2000-12-15
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-11-15
NYMOX PHARMACEUTICAL CORP, 424B3, 2000-10-12
NYMOX PHARMACEUTICAL CORP, 424B3, 2000-08-22
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-08-18
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-08-14
NYMOX PHARMACEUTICAL CORP, 6-K/A, 2000-05-19
NYMOX PHARMACEUTICAL CORP, 20-F, 2000-05-15
NYMOX PHARMACEUTICAL CORP, 6-K, 2000-05-15
NYMOX PHARMACEUTICAL CORP, F-1/A, 2000-03-09
NYMOX PHARMACEUTICAL CORP, F-1, 2000-02-29


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission